FDA Says No to the Senators Who Drafted DSHEA
According to our sources, the rogue agency is digging in its heels on the NDI draft guidance that threatens so many supplements, refusing to listen to Congress or follow the intent of the law.
How the FDA Turned a $10 Treatment into a $30,000-Per-Pregnancy Pharmaceutical Money-Maker
When a new FDA drug-and-money scandal has doctors, US senators, and even the March of Dimes in an uproar, you know it’s bad. A new Action Alert!
Watchdog Group Confuses Our Consumer Activists With “Well-Connected Lobbyists”!
A few weeks ago, Citizens for Responsibility and Ethics in Washington (CREW) released a report representing ANH-USA (and many other organizations’ efforts to protect natural health consumer rights) as “another disturbing example of pay-to-play in Washington.” Huh? Come again?
Breaking News: Court Overturns Ohio’s Attempt to Prevent Labeling of Hormone-Free Milk
This landmark court decision reaches far beyond Ohio. It means that milk—and maybe other food too—can be clearer about its origins.
Alert! Food Safety Bill Bad for Supplements (Ties U.S. to Codex) and Gives FDA Control Over Farming
The Senate’s “Food Safety” bill is better than the House’s in some important respects. For example, it drops the draconian jail sentences and fines for vague infractions including paperwork errors. But it includes a Codex provision that absolutely must be removed by amendment in order to protect free choice about supplements. Please take action to […]
Time To Make Your Voice Heard on Electronic Medical Records
When Security is Breached, What Happens Public comments are being accepted through June 1, 2009, by the Federal Trade Commission (FTC) on a proposed rule that would require notification of consumers when the security of their electronic health information is breached. According to healthcare attorney W. Reece Hirsch, the FTC is under a tight schedule […]
What Effects Will the Pending FDA Regulation Changes Have on Stevia and Other Substances?
The FDA is currently receiving comment about Section 912 of its Amendments Act (FDAAA), which deals with the regulation of foods containing substances that have undergone clinical trials; they have now extended that comment period until November 25. The Section 912 regulations could create a major shift in the divide between foods and drugs.